Pharma-Biotech Industry's 2007 Capital Investment Review: North American Construction Starts Jump 22% to $13.9 Billion
Pharma-Biotech Industry's 2007 Capital Investment Review: North American Construction Starts Jump 22% to $13.9 Billion
Attachment: 2007 North American Pharma-Biotech Industry Project Starts
The 2007 figures demonstrated an increase of $2.5 billion, or 22%, in reported project starts over 2006 and its $11.4 billion in TIV for 248 projects.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
